Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer

Abstract

The degree and type of T cell infiltration influence rectal cancer prognosis regardless of classical tumor staging. We asked whether clonal expansion and tumor infiltration are restricted to selected-phenotype T cells; which clones are accessible in peripheral blood; and what the spatial distribution of their target antigens is. From five rectal cancer patients, we isolated paired tumor-infiltrating T cells (TILs) and T cells from unaffected rectum mucosa (T UM) using 13-parameter FACS single cell index sorting. TCRαβ sequences, cytokine, and transcription factor expression were determined with single cell sequencing. TILs and T UM occupied distinct phenotype compartments and clonal expansion predominantly occurred within CD8 + T cells. Expanded TIL clones identified by paired TCRαβ sequencing and exclusively detectable in the tumor showed characteristic PD-1 and TIM-3 expression. TCRβ repertoire sequencing identified 49 out of 149 expanded TIL clones circulating in peripheral blood and 41 (84%) of these were PD-1 − TIM-3 −. To determine whether clonal expansion of predominantly tumor-infiltrating T cell clones was driven by antigens uniquely presented in tumor tissue, selected TCRs were reconstructed and incubated with cells isolated from corresponding tumor or unaffected mucosa. The majority of clones exclusively detected in the tumor recognized antigen at both sites. In summary, rectal cancer is infiltrated with expanded distinct-phenotype T cell clones that either i) predominantly infiltrate the tumor, ii) predominantly infiltrate the unaffected mucosa, or iii) overlap between tumor, unaffected mucosa, and peripheral blood. However, the target antigens of predominantly tumorinfiltrating TIL clones do not appear to be restricted to tumor tissue.

Personal tumor antigens in blood malignancies: genomics-directed identification and targeting

“…Personal antigen-directed therapeutic approaches have come a long way since the early days of HSCT and promise to remain a driving force for progress in hematology. The recent breathtaking technological advances have opened doors for a systematic understanding of target antigens (46,50,58), the identities and characteristics of subpopulations of TILs (160)(161)(162), and immunological aspects of disease biology (163).…”

Recognition of Immune Microenvironment Landscape and Immune-Related Prognostic Genes in Breast Cancer

“…Especially the degree and type of T cell infiltration affect the prognosis of breast cancer. Some studies in many human cancers have shown that the presence of T cell infiltration is often related to good prognosis [ 12 , 13 ]. In addition, high immune infiltration was associated with increased response to neoadjuvant and adjuvant chemotherapy [ 14 ].…”

Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment

“…Single-cell transcriptome analysis of immune cells in tumors provides a way to comprehensively study these cells in a highly complex tumor microenvironment (TME). Recently, single-cell RNA sequencing (scRNA-seq) has been applied to tumorinfiltrating immune cells isolated from limited types of cancers, including cutaneous melanoma 7,8 , non-small cell lung cancer 9,10 , hepatocellular carcinoma 11,12 , basal cell carcinoma 13 , colorectal cancer 14,15 , and breast cancer 16 . These studies uncover significant inter-tumoral and intra-tumoral heterogeneity in tumor immune profiles, diverse immunosuppressive populations, less-defined immune cell subsets, and signal transduction networks in related cancer types.…”